Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Itacitinib

EU orphan designation number: EU/3/17/1964   
Active ingredient: Itacitinib
Indication: Treatment of graft-versus-host disease
Sponsor: Incyte Biosciences Distribution B.V.
Paasheuvelweg 25, 1105 BP Amsterdam, Nederland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
19/01/2018 Orphan designation EMA/OD/169/17 (2018)385 of 17/01/2018
13/11/2018 Transfer of orphan designation EMA/OD/169/17/T/01 (2018)7573 of 9/11/2018